Notably, the ncRNA‐DNMT1 axis plays a critical role in mediating resistance to various chemotherapy agents, including cisplatin, doxorubicin and TMZ, by regulating the expression of essential miRNAs and promoting aberrant DNA methylation that impacts tumour cell sensitivity. Here, DNMT1 is linked to neoplasm.